Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 
Datenbankrecherche:

 

Can antivirulence drugs stop infections without causing resistance?

11.10.2011
Antivirulence drugs disarm pathogens rather than kill them, and although they could be effective in theory, antivirulence drugs have never been tested in humans. A new study to be published in the online journal mBio® on Tuesday, October 18 reveals these drugs have the potential to fight infection while avoiding the pitfalls of drug resistance.

Traditional antibiotics aim to kill or stop the growth of pathogens, but antivirulence drugs prevent disease by neutralizing virulence factors, the specific proteins or toxins that a pathogen uses to establish an infection.

Scientists have long thought such a strategy could prevent pathogens from developing drug resistance, since antivirulence drugs don't kill the pathogens that are susceptible and leave a wide opening for the few resistant organisms that may be left. Thus, in theory, antivirulence drugs don't offer much benefit to the pathogens that get around the drug. However, these ideas have never been tested.

The study coming out this week provides evidence that antivirulence drugs have the potential to suppress resistance if they are applied in the right way. Brett Mellbye and Martin Schuster from Oregon State University carried out laboratory simulations to determine the effect antivirulence drug-resistant strains could have on therapy. They found that in pathogens that rely on cell-to-cell communication and cooperation, resistant strains will not overtake sensitive strains, allowing antivirulence therapies that target social interactions to work even when resistance arises.

"It's a very important demonstration of the principle that social effects can slow or even halt the spread of resistance to antivirulence drugs," says Sam Brown, of Edinburgh University, Invited Editor on the study. "Their results align with our understanding of social evolution."

Mellbye and Schuster created a microcosm that simulates an infection, says Brown, and they used bacteria that employ quorum sensing, a form of communication that enables the bacteria to time their attack for greatest effect. Quorum sensing is an important target for antivirulence drugs because many bacterial pathogens, including the lung pathogen Pseudomonas aeruginosa, employ quorum sensing to control the manufacture of their virulence factors.

To circumvent the problem of creating a strain that is resistant to an antivirulence drug, Brown says, the authors used surrogates. "It's kind of a role-playing exercise," to test their ideas, he says. "They used bacteria that behave as we expect drug-resistant bacteria might behave." "Sensitive" mimics are bacteria that lack the ability to communicate and cooperate. "Resistant" mimics are actually run-of-the-mill bacteria that retain the ability to "talk" amongst themselves.

The researchers pitted resistant mimics against sensitive mimics to test whether resistant strains can proliferate in an infection. The results showed that sensitive mimics cheat to get ahead: they exploit the resources that the resistant bacteria provide through quorum sensing. This delays the growth of all the bacteria, suggesting that resistance to an antivirulence drug that targets quorum sensing would not spread. The authors say this highlights the potential of antivirulence strategies that target cooperative behaviors and shared virulence factors.

Brown is optimistic but circumspect about the findings. "These results could very well stand, but in the the real world resistance could still emerge and we need to be cautious."

"I think these drugs are promising, even if we do anticipate resistance, because they can slow the rate of resistance evolution, much slower than the rate of resistance evolution to traditional antibiotics," says Brown.

mBio® is an open access online journal published by the American Society for Microbiology to make microbiology research broadly accessible. The focus of the journal is on rapid publication of cutting-edge research spanning the entire spectrum of microbiology and related fields. It can be found online at http://www.mbio.asm.org

Jim Sliwa | EurekAlert!
Further information:
http://www.asmusa.org
http://www.mbio.asm.org

More articles from Health and Medicine:

nachricht Fiber optic biosensor-integrated microfluidic chip to detect glucose levels
29.04.2016 | The Optical Society

nachricht Got good fat?
27.04.2016 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: 2+1 ist nicht immer 3 - In der Mikro-Welt macht Einigkeit nicht immer stark

Wenn jemand ein liegengebliebenes Auto alleine schiebt, gibt es einen bestimmten Effekt. Wenn eine zweite Person hilft, ist das Ergebnis die Summe der Kräfte der beiden. Wenn zwei kleine Teilchen allerdings ein weiteres kleines Teilchen anschieben, ist der daraus resultierende Effekt nicht notwendigerweise die Summe ihrer Kräfte. Eine kürzlich in Nature Communications veröffentlichte Studie hat diesen merkwürdigen Effekt beschrieben, den Wissenschaftler als „Vielteilchen-Effekt“ bezeichnen.

 

Im Focus: 2+1 is Not Always 3 - In the microworld unity is not always strength

If a person pushes a broken-down car alone, there is a certain effect. If another person helps, the result is the sum of their efforts. If two micro-particles are pushing another microparticle, however, the resulting effect may not necessarily be the sum their efforts. A recent study published in Nature Communications, measured this odd effect that scientists call “many body.”

In the microscopic world, where the modern miniaturized machines at the new frontiers of technology operate, as long as we are in the presence of two...

Im Focus: Winzige Mikroroboter, die Wasser reinigen können

Forscher des Max-Planck-Institutes Stuttgart haben winzige „Mikroroboter“ mit Eigenantrieb entwickelt, die Blei aus kontaminiertem Wasser entfernen oder organische Verschmutzungen abbauen können.

In Zusammenarbeit mit Kollegen in Barcelona und Singapur verwendete die Gruppe von Samuel Sánchez Graphenoxid zur Herstellung ihrer Motoren im Mikromaßstab. D

Im Focus: Tiny microbots that can clean up water

Researchers from the Max Planck Institute Stuttgart have developed self-propelled tiny ‘microbots’ that can remove lead or organic pollution from contaminated water.

Working with colleagues in Barcelona and Singapore, Samuel Sánchez’s group used graphene oxide to make their microscale motors, which are able to adsorb lead...

Im Focus: Bewegungen in der lebenden Zelle beobachten

Prinzipien der statistischen Thermodynamik: Forscher entwickeln neue Untersuchungsmethode

Ein Forscherteam aus Deutschland, den Niederlanden und den USA hat eine neue Methode entwickelt, mit der sich Bewegungsprozesse in lebenden Zellen nach ihrem...

Alle Focus-News des Innovations-reports >>>

Anzeige

Anzeige

IHR
JOB & KARRIERE
SERVICE
im innovations-report
in Kooperation mit academics
Veranstaltungen

Internationale Bunsen-Tagung erstmals an Uni Rostock

02.05.2016 | Veranstaltungen

VDE|DGBMT veranstaltet Tagung zur patientennahen mobilen Diagnostik POCT

28.04.2016 | Veranstaltungen

Norddeutsche Herztage: 300 Experten treffen sich in Kiel

28.04.2016 | Veranstaltungen

 
B2B-VideoLinks
Weitere VideoLinks >>>
Aktuelle Beiträge

2+1 ist nicht immer 3 - In der Mikro-Welt macht Einigkeit nicht immer stark

02.05.2016 | Physik Astronomie

Messe: Heraeus Noblelight @ Drupa 2016

02.05.2016 | Messenachrichten

Single-Use TFF-System für große Volumina

02.05.2016 | Biowissenschaften Chemie